Wall Street Beat
MDT inks package of loans worth more than $16B to back its $43B acquisition of COV | Medtech Wall Street news for the week of November 10, 2014
Report: Actavis may buy Allergan for at least $60 billion
Medtech mergers stayed strong in Q3
Survey: Hospitals clamp down on medical device expenses
Lantheus resuscitates IPO
Lantheus Medical Imaging revived plans for an initial public offering last week, but didn’t set any terms for the flotation.
It’s the 2nd run at the public markets for Billerica, Mass.-based Lantheus, which makes medical imaging isotopes.
Medtronic inks $16B loan package for Covidien buyout
Salix inventory snafu sinks deal with Allergan
Fresenius ends Russia joint venture, feels impact of Ukraine crisis
The silver lining for healthcare in U.S. inversion rules
(Reuters) – Investors and bankers have been lamenting the potential death of large cross-border healthcare mergers since the U.S. Treasury Dept. announced in late September that it would curtail the tax breaks from international deals designed to give U.S. companies a legal home in a low-tax country.
Second Sight eyes $32m IPO
Second Sight Medical said today that it plans to raise $31.5 million in an initial public offering, likely next week.
Second Sight created the Argus II "bionic eye," the 1st retinal prosthesis approved for sale by the FDA.